购物车
全部删除
您的购物车当前为空
ML-335 是μ-δ异构体靶向激动剂,是一种μOR-δOR 偏向配体,可以作为开发独特类型(异构体偏倚)药物的支架。ML-335是MOR(μ阿片受体)/DOR(δ阿片受体)异构体, 具有抗伤害感受活性和抑制疼痛的活性。

ML-335 是μ-δ异构体靶向激动剂,是一种μOR-δOR 偏向配体,可以作为开发独特类型(异构体偏倚)药物的支架。ML-335是MOR(μ阿片受体)/DOR(δ阿片受体)异构体, 具有抗伤害感受活性和抑制疼痛的活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 130 | 现货 | |
| 5 mg | ¥ 289 | 现货 | |
| 10 mg | ¥ 482 | 现货 | |
| 25 mg | ¥ 993 | 现货 | |
| 50 mg | ¥ 1,530 | 现货 | |
| 100 mg | ¥ 2,290 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 323 | 现货 |
ML-335 相关产品
| 产品描述 | ML-335 is a μ-δ isomer-targeted agonist, a μOR-δOR-biased ligand that can serve as a scaffold for the development of unique types of (isomer-biased) drugs.ML-335 is a MOR (μ-opioid receptor)/DOR (δ-opioid receptor) heterodimer, with anti-injury sensory activity and pain inhibitory activity. |
| 靶点活性 | μ opioid receptor:0.125 µM(EC50) |
| 体内活性 | CYM51010(ML-335)(皮下注射;SNL大鼠)以剂量相关的方式抑制了机械性高敏感(EC50:1.09 mg/kg),同时也逆转了热痛觉过敏并减轻了持续性疼痛(2 mg/kg,皮下注射)[1]。 |
| 分子量 | 408.53 |
| 分子式 | C25H32N2O3 |
| CAS No. | 1069498-96-9 |
| Smiles | CCOC(=O)C1(CCc2ccccc2)CCN(Cc2ccc(NC(C)=O)cc2)CC1 |
| 密度 | no data available |
| 颜色 | Yellow |
| 物理性状 | Oil |
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 9 mg/mL (22.03 mM), Sonication is recommended. | |||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.45 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容